Conformance with USP chapter 729 for parenteral nutritional emulsions

American Journal of Health-System Pharmacy

Volumn 65, Issue 12, 2008, Pages 1117-1118

  Gonyon, Thomas ^a   Carter, Phillip W ^c   Trouilly, Jean Luc ^b  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b Baxter R and D Europe   (Belgium)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINOLEIC; INTRALIPID; IVELIP; LIPID; LIPID EMULSION; OIL; OLICLINOMEL; OLIVE OIL; SOYBEAN OIL;

ANALYZER; BIOSENSOR; INTRAVENOUS FEEDING; LETTER; PARENTERAL NUTRITION; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PRIORITY JOURNAL; REFRACTION INDEX; STANDARD;

EID: 45749112248     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080055     Document Type: Letter

References (3)

1. Globule size distribution in lipid injectable emulsions (general information chapter 729). In: The United States pharmacopeia, 30th rev., and The national formulary, 25th ed. Suppl 2. Rockville, MD: United States Pharmacopeial Convention; 2007:3968-70.
2. Driscoll DF, Etzler F, Barber TA et al. Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction. Int J Pharm. 2001; 219:21-37.
3. Gonyon T, Patel P, Owen H et al. Physicochemical stability of lipid injectable emulsions: correlating changes in large globule distributions with phase separation behavior. Int J Pharm. 2007; 343:208-19.